Holen Sie sich die Stockscreener-App
1.08
1.82%
-0.02
Schlusskurs vom Vortag:
$1.10
Offen:
$1.14
24-Stunden-Volumen:
4,291
Relative Volume:
0.50
Marktkapitalisierung:
$925.46M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-2.25M
KGV:
-2.70
EPS:
-0.4
Netto-Cashflow:
-
1W Leistung:
-12.90%
1M Leistung:
-14.96%
6M Leistung:
-40.98%
1J Leistung:
-61.43%
1-Tages-Spanne:
$1.05
$1.14
1-Wochen-Bereich:
$1.03
$1.25
52-Wochen-Spanne:
$0.9208
$3.05
X T L Biopharmaceuticals Ltd Adr Stock (XTLB) Company Profile
Firmenname
X T L Biopharmaceuticals Ltd Adr
Sektor
Branche
Telefon
-
Adresse
-
Vergleichen Sie XTLB mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
XTLB
X T L Biopharmaceuticals Ltd Adr
|
1.05 | 11.03M | 0 | -2.25M | 0 | -0.40 |
|
ONC
Beigene Ltd Adr
|
235.19 | 24.29B | 3.81B | -644.79M | -669.77M | -6.24 |
|
VRTX
Vertex Pharmaceuticals Inc
|
434.02 | 110.94B | 11.10B | -988.90M | -1.26B | -3.92 |
|
AKTX
Akari Therapeutics Plc Adr
|
1.3064 | 45.05M | 0 | 0 | 0 | 0.00 |
|
REGN
Regeneron Pharmaceuticals Inc
|
599.77 | 61.99B | 14.09B | 4.50B | 2.96B | 39.28 |
|
VRNA
Verona Pharma Plc Adr
|
73.01 | 5.75B | 0 | -153.72M | -103.81M | -2.00 |
X T L Biopharmaceuticals Ltd Adr Stock (XTLB) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2015-05-08 | Eingeleitet | H.C. Wainwright | Buy |
X T L Biopharmaceuticals Ltd Adr Aktie (XTLB) Neueste Nachrichten
XTL Biopharmaceuticals Appoints Noam Band as CEO - TipRanks
XTL Biopharmaceuticals Enters Sublicense Agreement with Biossil - TipRanks
XTL Biopharmaceuticals Adjusts Board Representation Amid Resignations - TipRanks
Form N-CSR FIDELITY CONCORD STREET For: Nov 30 - StreetInsider.com
XTL Biopharmaceuticals Expands Portfolio with Social Proxy Acquisition Amidst Regional Challenges - TipRanks
XTL Biopharmaceuticals Adjusts Shares, Eyes Expansion - TipRanks
XTL Biopharmaceuticals Resolves Dispute with Social Proxy - TipRanks
XTL Biopharmaceuticals Faces Financial Dispute After Acquisition - TipRanks
symbol__ Stock Quote Price and Forecast - CNN
Crude Oil Dips 2%; Signet Jewelers Shares Spike Higher - Markets Insider
Benzinga's Daily Biotech Pulse: Karyopharm's STORM Study, Inogen Rallies On Earnings - Yahoo Finance
Finanzdaten der X T L Biopharmaceuticals Ltd Adr-Aktie (XTLB)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.76%
2.08%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):